New Partnerships With Leading FirmsGemma Cann2024-11-28T15:16:48+00:00January 25th, 2022|Accelerator, News|
Pioneer Group Accelerator Winner AnnouncedGemma Cann2023-09-04T12:44:36+01:00January 21st, 2022|Accelerator, News|
Sygnature Discovery Appoints Dr Charles Woler As ChairmanGemma Cann2024-11-28T15:17:03+00:00January 14th, 2022|BioCity Nottingham, News|
NuVision Biotherapies Announces The Appointment Of New CEO And COOGemma Cann2024-11-28T15:30:12+00:00January 14th, 2022|MediCity Nottingham, News|
Gateley Acquires IP Specialists Adamson JonesGemma Cann2022-06-30T11:45:01+01:00January 13th, 2022|BioCity Nottingham, News|
Oxomics’ New Blood-Based Test The First To Identify If A Patient Has Cancer And If It Has SpreadGemma Cann2024-11-28T16:54:08+00:00January 11th, 2022|News|
Novosound Enters Global Digital Health MarketGemma Cann2022-06-30T11:46:29+01:00January 5th, 2022|BioCity Glasgow, News|
Pioneer Group Accelerator Winner Announced: Pioneering Start-up Oxomics Receives £50KGemma Cann2023-09-04T12:48:30+01:00December 17th, 2021|Accelerator, News|
Finalists Announced For The Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:30:27+00:00December 15th, 2021|BioCity Nottingham, MediCity Nottingham, News|
Symrise Opens Innovation Lab Located At Colworth Science ParkGemma Cann2024-11-28T15:21:14+00:00December 15th, 2021|Colworth Park, News|
